세계의 상피 성장인자 패치 시장 보고서(2025년)

An epidermal growth factor patch is a transdermal patch designed to deliver epidermal growth factor directly through the skin to stimulate cell regeneration, repair, and healing. It is commonly used in medical and skincare applications to promote wound healing, reduce scarring, and enhance skin elasticity and appearance.

The primary product types of epidermal growth factor patch are hydrogel patches, microneedle patches, film patches, and other variants. Hydrogel patches are made from hydrogel and deliver epidermal growth factor directly to the skin, supporting cell regeneration, wound healing, scar reduction, and anti-aging effects. These patches are used for wound healing, anti-aging, scar treatment, skin rejuvenation, and other applications. Distribution channels include online pharmacies, retail pharmacies, hospital pharmacies, and other outlets. Key end-users include hospitals and clinics, dermatology centers, homecare providers, and related facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The epidermal growth factor patch market research report is one of a series of new reports from The Business Research Company that provides epidermal growth factor patch market statistics, including epidermal growth factor patch industry global market size, regional shares, competitors with an epidermal growth factor patch market share, detailed epidermal growth factor patch market segments, market trends and opportunities, and any further data you may need to thrive in the epidermal growth factor patch industry. This epidermal growth factor patch market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The epidermal growth factor patch market size has grown rapidly in recent years. It will grow from $1.10 billion in 2024 to $1.25 billion in 2025 at a compound annual growth rate (CAGR) of 13.9%. The growth in the historic period is attributed to the increasing incidence of diabetic ulcers, growing consumer interest in scar reduction, rising numbers of cosmetic and plastic surgeries, higher prevalence of lifestyle-related skin disorders, and stronger preference for non-invasive healing solutions.

The epidermal growth factor patch market size is expected to see rapid growth in the next few years. It will grow to $2.08 billion in 2029 at a compound annual growth rate (CAGR) of 13.6%. The growth in the forecast period is driven by rising demand for personalized skincare solutions, greater adoption of advanced wound healing products, increased awareness of bioactive cosmetic patches, expanding use in postoperative recovery, and growing preference for non-surgical skin treatments. Key trends in the forecast period include advancements in bioactive patch formulations, development of combination therapy patches, innovation in sustained-release delivery systems, progress in biodegradable and eco-friendly materials, and creation of multifunctional skincare patches.

The growing demand for personalized medicine is expected to drive the expansion of the epidermal growth factor patch market in the future. Personalized medicine involves tailoring treatment and prevention strategies to a person's unique genetic makeup, lifestyle, and environmental factors. The increasing use of personalized medicine is mainly attributed to advancements in genomics, which allow for the precise identification of genetic variations and the development of individualized treatments. Epidermal Growth Factor (EGF) patches enhance personalized medicine by delivering growth factors directly to the target area, making them effective for wound healing and skin regeneration. They help reduce recovery time by stimulating cell proliferation and tissue repair, thus improving treatment outcomes for individual patients. For example, in February 2024, the Personalized Medicine Coalition, a nonprofit organization in the United States, reported that the U.S. Food and Drug Administration approved 26 new personalized medicines in 2023, up from 12 in 2022. As a result, the increasing demand for personalized medicine is contributing to the growth of the epidermal growth factor patch market.

The rising prevalence of skin disorders is expected to drive the growth of the epidermal growth factor patch market. Skin disorders are conditions that affect the skin's appearance, structure, or function, often causing symptoms such as inflammation, irritation, or abnormal growths. These conditions include acne, eczema, psoriasis, dermatitis, vitiligo, fungal infections, warts, and skin cancer. The prevalence of these disorders is increasing due to environmental pollution, which can damage the skin barrier and trigger inflammatory or allergic reactions. Epidermal growth factor patches help manage skin disorders by delivering growth factors directly to the affected area, making them effective for treating wounds, burns, and chronic ulcers. They speed up the healing process by promoting cell regeneration and tissue repair, improving patient recovery and overall treatment results. For instance, in 2023, Cancer Australia reported that around 8,257 new cases of melanoma were diagnosed, representing 2.6% of all cancer-related deaths. Therefore, the rising prevalence of skin disorders is driving the growth of the epidermal growth factor patch market.

The growing popularity of personal care products is expected to support the growth of the epidermal growth factor patch market. Personal care products include items and formulations used for personal hygiene, grooming, and enhancing physical appearance, such as skincare, hair care, oral care, and cosmetics. This increase in demand is driven by a rising awareness of hygiene and health, as people become more conscious of the importance of cleanliness, infection prevention, and overall well-being. Epidermal growth factor patches complement personal care products by promoting skin regeneration and hydration, making them ideal for anti-aging and skin repair routines. They help improve skin texture and reduce the appearance of fine lines by stimulating cell growth, enhancing overall skin health, and achieving better cosmetic results. For example, in September 2024, the Bureau of Labor Statistics reported that the expenditure on personal care products and services in the United States reached $950 in 2023, a 9.7% increase from $866 in 2022. As a result, the growing demand for personal care products is contributing to the expansion of the epidermal growth factor patch market.

Major players in the epidermal growth factor patch market are Nissha Co. Ltd., Daewoong Pharmaceutical Co. Ltd., Kindeva Drug Delivery L.L.C., LTS Lohmann Therapie-Systeme AG, Teikoku Seiyaku Co. Ltd., Katecho Inc., QuadMedicine Inc., Vaxxas Pty Ltd., DermaJect AB, Micropoint Technologies Ltd., CD Bioparticles Inc., CosMED Pharmaceutical Co. Ltd., Alliqua BioMedical Inc., NEXGEL Inc., Pocono Pharma Inc., Micron Biomedical Inc., Raphas Co. Ltd., Heber Biotech S.A., Zosano Pharma Corporation, and Hebei Feifan Biotechnology Co. Ltd.

North America was the largest region in the epidermal growth factor patch market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in epidermal growth factor patch report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the epidermal growth factor patch market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The epidermal growth factor patch market consists of sales of anti-aging patches, wound healing patches, acne treatment patches, under-eye patches, and scar reduction patches. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Epidermal Growth Factor Patch Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on epidermal growth factor patch market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for epidermal growth factor patch ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The epidermal growth factor patch market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Hydrogel Patches; Microneedle Patches; Film Patches; Other Product Types
• 2) By Application: Wound Healing; Anti-Aging; Scar Treatment; Skin Rejuvenation; Other Applications
• 3) By Distribution Channel: Online Pharmacies; Retail Pharmacies; Hospital Pharmacies; Other Distribution Channels
• 4) By End-User: Hospitals And Clinics; Dermatology Centers; Home Care; Other End-Users
• Subsegments:
• 1) By Hydrogel Patches: Moisturizing Repair; Anti Aging; Scar Reduction; Wound Healing
• 2) By Microneedle Patches: Epidermal Growth Factor Delivery; Vaccine Delivery; Pain Management; Cosmetic Treatment
• 3) By Film Patches: Skin Brightening; Anti Wrinkle; Acne Treatment; Hydration Boost
• 4) By Other Product Types: Cooling Soothing; Anti Inflammatory; Detoxifying; Skin Firming
• Companies Mentioned: Nissha Co. Ltd.; Daewoong Pharmaceutical Co. Ltd.; Kindeva Drug Delivery L.L.C.; LTS Lohmann Therapie-Systeme AG; Teikoku Seiyaku Co. Ltd.; Katecho Inc.; QuadMedicine Inc.; Vaxxas Pty Ltd.; DermaJect AB; Micropoint Technologies Ltd.; CD Bioparticles Inc.; CosMED Pharmaceutical Co. Ltd.; Alliqua BioMedical Inc.; NEXGEL Inc.; Pocono Pharma Inc.; Micron Biomedical Inc.; Raphas Co. Ltd.; Heber Biotech S.A.; Zosano Pharma Corporation; Hebei Feifan Biotechnology Co. Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Epidermal Growth Factor Patch Market Characteristics

3. Epidermal Growth Factor Patch Market Trends And Strategies

4. Epidermal Growth Factor Patch Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Epidermal Growth Factor Patch Growth Analysis And Strategic Analysis Framework

• 5.1. Global Epidermal Growth Factor Patch PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Epidermal Growth Factor Patch Market Growth Rate Analysis
• 5.4. Global Epidermal Growth Factor Patch Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Epidermal Growth Factor Patch Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Epidermal Growth Factor Patch Total Addressable Market (TAM)

6. Epidermal Growth Factor Patch Market Segmentation

• 6.1. Global Epidermal Growth Factor Patch Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hydrogel Patches
• Microneedle Patches
• Film Patches
• Other Product Types
• 6.2. Global Epidermal Growth Factor Patch Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Wound Healing
• Anti-Aging
• Scar Treatment
• Skin Rejuvenation
• Other Applications
• 6.3. Global Epidermal Growth Factor Patch Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Online Pharmacies
• Retail Pharmacies
• Hospital Pharmacies
• Other Distribution Channels
• 6.4. Global Epidermal Growth Factor Patch Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Clinics
• Dermatology Centers
• Home Care
• Other End-Users
• 6.5. Global Epidermal Growth Factor Patch Market, Sub-Segmentation Of Hydrogel Patches, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Moisturizing Repair
• Anti Aging
• Scar Reduction
• Wound Healing
• 6.6. Global Epidermal Growth Factor Patch Market, Sub-Segmentation Of Microneedle Patches, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Epidermal Growth Factor Delivery
• Vaccine Delivery
• Pain Management
• Cosmetic Treatment
• 6.7. Global Epidermal Growth Factor Patch Market, Sub-Segmentation Of Film Patches, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Skin Brightening
• Anti Wrinkle
• Acne Treatment
• Hydration Boost
• 6.8. Global Epidermal Growth Factor Patch Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cooling Soothing
• Anti Inflammatory
• Detoxifying
• Skin Firming

7. Epidermal Growth Factor Patch Market Regional And Country Analysis

• 7.1. Global Epidermal Growth Factor Patch Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Epidermal Growth Factor Patch Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Epidermal Growth Factor Patch Market

• 8.1. Asia-Pacific Epidermal Growth Factor Patch Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Epidermal Growth Factor Patch Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Epidermal Growth Factor Patch Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Epidermal Growth Factor Patch Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Epidermal Growth Factor Patch Market

• 9.1. China Epidermal Growth Factor Patch Market Overview
• 9.2. China Epidermal Growth Factor Patch Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Epidermal Growth Factor Patch Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Epidermal Growth Factor Patch Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Epidermal Growth Factor Patch Market

• 10.1. India Epidermal Growth Factor Patch Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Epidermal Growth Factor Patch Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Epidermal Growth Factor Patch Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Epidermal Growth Factor Patch Market

• 11.1. Japan Epidermal Growth Factor Patch Market Overview
• 11.2. Japan Epidermal Growth Factor Patch Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Epidermal Growth Factor Patch Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Epidermal Growth Factor Patch Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Epidermal Growth Factor Patch Market

• 12.1. Australia Epidermal Growth Factor Patch Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Epidermal Growth Factor Patch Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Epidermal Growth Factor Patch Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Epidermal Growth Factor Patch Market

• 13.1. Indonesia Epidermal Growth Factor Patch Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Epidermal Growth Factor Patch Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Epidermal Growth Factor Patch Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Epidermal Growth Factor Patch Market

• 14.1. South Korea Epidermal Growth Factor Patch Market Overview
• 14.2. South Korea Epidermal Growth Factor Patch Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Epidermal Growth Factor Patch Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Epidermal Growth Factor Patch Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Epidermal Growth Factor Patch Market

• 15.1. Western Europe Epidermal Growth Factor Patch Market Overview
• 15.2. Western Europe Epidermal Growth Factor Patch Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Epidermal Growth Factor Patch Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Epidermal Growth Factor Patch Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Epidermal Growth Factor Patch Market

• 16.1. UK Epidermal Growth Factor Patch Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Epidermal Growth Factor Patch Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Epidermal Growth Factor Patch Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Epidermal Growth Factor Patch Market

• 17.1. Germany Epidermal Growth Factor Patch Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Epidermal Growth Factor Patch Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Epidermal Growth Factor Patch Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Epidermal Growth Factor Patch Market

• 18.1. France Epidermal Growth Factor Patch Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Epidermal Growth Factor Patch Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Epidermal Growth Factor Patch Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Epidermal Growth Factor Patch Market

• 19.1. Italy Epidermal Growth Factor Patch Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Epidermal Growth Factor Patch Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Epidermal Growth Factor Patch Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Epidermal Growth Factor Patch Market

• 20.1. Spain Epidermal Growth Factor Patch Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Epidermal Growth Factor Patch Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Epidermal Growth Factor Patch Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Epidermal Growth Factor Patch Market

• 21.1. Eastern Europe Epidermal Growth Factor Patch Market Overview
• 21.2. Eastern Europe Epidermal Growth Factor Patch Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Epidermal Growth Factor Patch Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Epidermal Growth Factor Patch Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Epidermal Growth Factor Patch Market

• 22.1. Russia Epidermal Growth Factor Patch Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Epidermal Growth Factor Patch Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Epidermal Growth Factor Patch Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Epidermal Growth Factor Patch Market

• 23.1. North America Epidermal Growth Factor Patch Market Overview
• 23.2. North America Epidermal Growth Factor Patch Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Epidermal Growth Factor Patch Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Epidermal Growth Factor Patch Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Epidermal Growth Factor Patch Market

• 24.1. USA Epidermal Growth Factor Patch Market Overview
• 24.2. USA Epidermal Growth Factor Patch Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Epidermal Growth Factor Patch Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Epidermal Growth Factor Patch Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Epidermal Growth Factor Patch Market

• 25.1. Canada Epidermal Growth Factor Patch Market Overview
• 25.2. Canada Epidermal Growth Factor Patch Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Epidermal Growth Factor Patch Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Epidermal Growth Factor Patch Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Epidermal Growth Factor Patch Market

• 26.1. South America Epidermal Growth Factor Patch Market Overview
• 26.2. South America Epidermal Growth Factor Patch Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Epidermal Growth Factor Patch Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Epidermal Growth Factor Patch Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Epidermal Growth Factor Patch Market

• 27.1. Brazil Epidermal Growth Factor Patch Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Epidermal Growth Factor Patch Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Epidermal Growth Factor Patch Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Epidermal Growth Factor Patch Market

• 28.1. Middle East Epidermal Growth Factor Patch Market Overview
• 28.2. Middle East Epidermal Growth Factor Patch Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Epidermal Growth Factor Patch Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Epidermal Growth Factor Patch Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Epidermal Growth Factor Patch Market

• 29.1. Africa Epidermal Growth Factor Patch Market Overview
• 29.2. Africa Epidermal Growth Factor Patch Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Epidermal Growth Factor Patch Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Epidermal Growth Factor Patch Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Epidermal Growth Factor Patch Market Competitive Landscape And Company Profiles

• 30.1. Epidermal Growth Factor Patch Market Competitive Landscape
• 30.2. Epidermal Growth Factor Patch Market Company Profiles
  • 30.2.1. Nissha Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Daewoong Pharmaceutical Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Kindeva Drug Delivery L.L.C. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. LTS Lohmann Therapie-Systeme AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Teikoku Seiyaku Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Epidermal Growth Factor Patch Market Other Major And Innovative Companies

• 31.1. Katecho Inc.
• 31.2. QuadMedicine Inc.
• 31.3. Vaxxas Pty Ltd.
• 31.4. DermaJect AB
• 31.5. Micropoint Technologies Ltd.
• 31.6. CD Bioparticles Inc.
• 31.7. CosMED Pharmaceutical Co. Ltd.
• 31.8. Alliqua BioMedical Inc.
• 31.9. NEXGEL Inc.
• 31.10. Pocono Pharma Inc.
• 31.11. Micron Biomedical Inc.
• 31.12. Raphas Co. Ltd.
• 31.13. Heber Biotech S.A.
• 31.14. Zosano Pharma Corporation
• 31.15. Hebei Feifan Biotechnology Co. Ltd.

32. Global Epidermal Growth Factor Patch Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Epidermal Growth Factor Patch Market

34. Recent Developments In The Epidermal Growth Factor Patch Market

35. Epidermal Growth Factor Patch Market High Potential Countries, Segments and Strategies

• 35.1 Epidermal Growth Factor Patch Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Epidermal Growth Factor Patch Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Epidermal Growth Factor Patch Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer